Synthesis of 1-(dihydroxypropyl)-5-substituted uracils

Tetrahedron Letters

Volumn 44, Issue 39, 2003, Pages 7291-7293

  Gondela, Andrzej ^a   Walczak, Krzysztof ^a  

^a SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

1 (dihydroxypropyl) 5 substituted uracils; Aminopropanediols; Enantiomers

Indexed keywords

3 AMINO 1,2 PROPANEDIOL; ALCOHOL DERIVATIVE; OLIGONUCLEOTIDE; PROPANEDIOL DERIVATIVE; PROPYLAMINE; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ARTICLE; CHEMICAL REACTION; DRUG SYNTHESIS; ENANTIOMER; MEDICAL LITERATURE; QUANTITATIVE ANALYSIS; RACEMIC MIXTURE; ROOM TEMPERATURE;

EID: 0041880584     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(03)01872-0     Document Type: Article

References (24)

1. Garg R., Gupta S.P., Gao H., Babu M.S., Debnath A.K., Hansch C. Chem. Rev. 99:1999;3525-3601.
2. Abushanab E. Chu C.K., Baker D.C. Nucleosides and Nucleotides as Antitumor and Antiviral Agents. 1993;159-171 Plenum Press, New York.
3. Seeberger, P. H.; Caruthers, M. H. In Applied Antisense Oligonucleotide Technology; Stein, C. D.; Krieg, A. M., Eds.; Modified Oligonucleotides as Antisense Therapeutics; Wiley-Liss: New York, 1998; Chapter 3, pp. 51-72.
4. Seeberger, P. H.; Caruthers, M. H. In Applied Antisense Oligonucleotide Technology; Stein, C. D.; Krieg, A. M., Eds.; Modified Oligonucleotides as Antisense Therapeutics; Wiley-Liss: New York, 1998; Chapter 3, pp. 51-72.
5. Efimtseva E.V., Mikhailov S.N., Meshkov S., Hankamaki T., Oivanen M., Lonberg H. J. Chem. Soc., Perkin Trans. 1. 1995;1409-1415.
6. Cadet G., Chan Ch.S., Daniel R.Y., Davis C.P., Guiadeen D., Rodriguez G., Thomas T., Walcott S., Scheiner P. J. Org. Chem. 63:1998;4574-4580.
7. Suwiński J., Szczepankiewicz W., Świerczek K., Walczak K. Eur. J. Org. Chem. 2003;1080-1084.
8. Hirota K., Kitade Y., Sajiki H., Maki Y. Tetrahedron Lett. 27:1986;3263-3266.
9. Hirota K., Kitade Y., Sajiki H., Maki Y. J. Chem. Soc., Perkin Trans. 1. 1990;367-373.
10. Senda S., Hirota K., Notani J. Chem. Pharm. Bull. 20:1972;1389-1396.
11. Washtien W.L., Santi D.V. J. Med. Chem. 25:1982;1252-1255.
12. Trusule M., Kupce E., Augustane I., Verovskii N.V., Lukevics E., Baumane L., Gavars R., Stradins J. Khim. Geterocycl. Soedin. 12:1991;1687-1694.
13. Kranz P., Lee C.S., Gero A.M., O'Sullivan W.J. Biochem. Pharmacol. 38:1989;3785-3789.
14. Copik A., Suwinski J., Walczak K., Bronikowska J., Czuba Z., Król W. Nucleosides, Nucloetides Nucleic Acids. 21:2002;377-383.
15. Acevedo O.L., Andrews R.S. Tetrahedron Lett. 37:1996;3931-3934.
16. 6 (245.2): %C, 39.39; %H, 4.52; %N, 17.14. Found: %C, 39.30; %H, 4.52; %N, 16.95.
17. Wolfbeis O.S. Liebigs Ann. Chem. 1982;182-185.
18. 2), 8.37 (s, 1H, H-6), 8.38 (d, 2H, J=9.3 Hz, Ar).
19. 5 (243.22): %C, 44.44; %H, 5.40; %N, 17.28. Found: %C, 44.46; %H, 5.61; %N, 16.97.
20. 13C NMR, (DMSO): δ (ppm)=25.16, 26.44, 28.02, 51.21, 65.82, 73.03, 103.94, 108.94, 150.17, 150.65, 162.32, 162.96.
21. Kool E.T. Acc. Chem. Res. 35:2002;936-943.
22. Loakes D. Nucleic Acids Res. 29:2001;2437-2447.
23. Kool E.T. Biopolymers. 48:1998;3-17.
24. Berger M., Wu Y., Ogawa A.K., McMinn D.L., Schultz P.G., Romesberg F.E. Nucleic Acids Res. 28:2000;2911-2914.